2020 SAPA-DC Biotech Investors Pitch Conference

CONNECTpreneur presents:

"2020 SAPA-DC Biotech Investors Pitch Conference"

A virtual event bridging capital and projects between the US and China.

Welcome to our first virtual Biotech Investors Pitch Conference! The event features a Rocket Pitch segment with 10 exciting biotechnology companies, informative plenary talks and panel discussions with top experts in the cross-border biotech start-up and investment ecosystem, plus two virtual networking sessions!

Program Highlights:

- More than 500 business leaders, including 150+ CEOs, founders, angels & VC/PE investors from around the US and greater China.

- Showcase of 10 promising life sciences companies.

- Virtual networking pre- and post-program. We will keep the meeting open for as long as our attendees are actively networking (30-45+ minutes).

SAPA-DC's key partner on this event is CONNECTpreneur (www.connectpreneur.org), a global community of 20,000+ entrepreneurs, investors, and business leaders.

All attendees must pre-register on the Eventbrite site.

We will email you the log-in information and instructions after you register. Emails will be sent on the afternoon/evening of October 16.

We also welcome you to fill out the following forms to get more involved and extra benefits.

Sign up link for Entrepreneurs:https://forms.gle/13gaCfE4pKkyJQaF8

Sign up link for Investors: https://forms.gle/Jq5qVih3ngLbgBrw6

Sign up link for Business Development professionals:https://forms.gle/cit4atktBtdHt42o6

Sign up link for Sponsors and Media Partners: https://forms.gle/MMKkZvwbJu18M7hE6

Please "Like" us on Facebook: https://www.facebook.com/Sapa-dc-102695131502335

Follow us on Twitter @dcsapa

Follow us on LinkedIn: https://www.linkedin.com/company/sino-american-pharmaceutical-professionals-association-washington-dc-baltimore/

Visit our website at sapadc.org

And become a SAPA-DC member: https://www.eventbrite.com/e/sapa-dc-personal-membership-tickets-120106498771

CONFIRMED SPEAKERS AND PANELISTS

1. Lawrence Jin, Partner, Deloitte China Life Sciences and Health Care (LSHC) National Audit Leader

2. Dr. Yi Shi, Founding Managing Partner, Lilly Asia Ventures (LAV)

3. Dr. Xianping Lu, Chairman and CEO, Chipscreen Biosciences

4. Dr. Frank Fan, Cofounder and CSO, Legend Biotech

5. Dr. Debra Yu, President and CBO, LianBio

6. Konstantin Poukalov, Managing Director, Perceptive Advisors

7. Dr. Karen Hong, Partner, Novo Ventures

8. Dr. Marietta Wu, Managing Director, Quan Capital

9. Dr. Jing-Shan “Jennifer” Hu, Senior Advisor, Qiming Venture Partners USA

10. Dr. Li Feng, Partner, Finnegan

11. Lili Zheng, International Tax Partner, Deputy Managing Partner of Deloitte US Chinese Services Group, Asia Pacific Cross-Border Services Leader

12. Will Cai, Partner, Cooley LLP

13. Dr. John Mumm, Co-founder and CEO, Deka Biosciences

DATE: SATURDAY, OCTOBER 17, 2020

AGENDA (All times are Eastern Daylight Time)

8:30-9:05 AM - VIRTUAL NETWORKING (via Private Message)

9:05-9:15 AM - WELCOME and OPENING REMARKS, Lingquan “Vince” Deng, Ph.D., President of SAPA-DC

9:15-9:35 AM - KEYNOTE: “China Biotech/Life Sciences and Investment Landscape”, Lawrence Jin, China Life Sciences and Health Care (LSHC) National Audit Leader, Partner of Deloitte

9:35-9:55 AM - KEYNOTE: “Personal Perspectives from a Leading VC on Investing in China”, Yi Shi, Ph.D., Founding Managing Partner of Lilly Asia Ventures (LAV)

9:55-10:10 AM - PRESENTATION: “When Will We See China-Based Global Biotech Companies? An Insider’s View”, Xianping Lu, Ph.D., Chairman and CEO of Chipscreen Biosciences

10:10-10:25 AM - PRESENTATION: “Legend Biotech’s China and Global Development Story”, Frank Fan, Ph.D., Co-Founder and CSO of Legend Biotech

10:25-11:25 AM - Biotech Pitch Session: 10 promising biotech companies

Companies will be introduced by Tien Wong, Managing General Partner, Opus8 Phoenix Fund and Founder & Host of CONNECTpremeur Community

Adaptive Phage Therapeutics

Alphyn Biologics

AxImmune

BioFactura

BiOne Cure Therapeutics

DEKA BioSciences

Hopstem Biotechnology

LinkedUp Bioscience

Pendrea Pharmaceuticals

VerImmune

11:25-12:05 PM - Panel Discussion #1 (Co-organized with ChinaBio): Trends and Considerations for Biotech Investors

Moderator and panelists:

Dr. Debra Yu, President and CBO, LianBio

Konstantin Poukalov, Managing Director, Perceptive Advisors

Dr. Karen Hong, Partner, Novo Ventures

Dr. Marietta Wu, Managing Director, Quan Capital

Dr. Jing-Shan “Jennifer” Hu, Senior Advisor, Qiming Venture Partners USA

12:05-12:45 PM - Panel Discussion #2 (Sponsored by Hankang Capital): Opportunities and Challenges in Biotech Start-up, Growth and IPO

Moderator and panelists:

Dr. Li Feng, Partner, Finnegan

Lili Zheng, International Tax Partner, Deputy Managing Partner of Deloitte US Chinese Services Group, Asia Pacific Cross-Border Services Leader

Will Cai, Partner, Cooley LLP

Dr. John Mumm, Co-founder and CEO, Deka Biosciences

12:45-1:30 PM - COMPANY AND SERVICE SHOWCASE & VIRTUAL NETWORKING (via Private Message)

INVESTOR PARTICIPANTS AT OUR PREVIOUS EVENTS AND/OR INVITED THIS TIME (partial list):

I. US-based:

Carlyle Group, NEA, VIVO Ventures, Revolution Ventures, Kinetic Ventures, Sterling Partners, Core Capital, Grotech, UPDATA, In-Q-Tel, New Atlantic Ventures, PROOF.VC, Edison Ventures, SWaN & Legend Venture Partners, Venturehouse, Boulder Ventures, TDF Funds, Ballast Point Ventures, Multiplier Capital, Saratoga Investment Corp., Maryland Venture Fund, New Markets Venture Partners, True Ventures, 500 Startups, DFW Capital Partners, Farragut Capital, NextGen Angels, CIT GAP Funds, TEDCO, BluVenture Investors, Leeds Novamark, 1776, Private Access Network, CAV Angels, Riverbend Capital, K Street Capital, Select Venture Partners, RLMcCall Capital, ID Private Equity, Cranbrook Capital, Baltimore Angels, SaaS Ventures, Pennington Partners, Acceleprise, Blue Marlin Partners, US Boston Capital, VentureCross Partners, Dingman Angels, Neuberger & Co. Ventures, McLean Capital, Hercules Technology Growth Capital, Keiretsu Forum, Diamond Tech Ventures, BroadOak Capital Partners, Loncar Investments, F-Prime Capital, WI Harper Group, Bridge Point Capital, Sunwater Capital, Phoenix Fund, World Tech Ventures, and Manhattan Capital Group

II. Greater China-based:

Hillhouse Capital (高瓴资本), Sequoia Capital China(红杉资本中国), Qiming Venture Partners(启明创投), Lilly Asia Ventures (礼来亚洲基金),Kaitai Capital(凯泰资本),Loyal Valley Capital(正心谷资本), Huagai Capital(华盖资本), Vivo Capital(维梧资本), Northern Light Venture Capital(北极光创投),Quan Capital(泉创资本), Hankang Capital(漢康資本), Jianxin Capital(建信资本), IDG Capital (IDG资本),Share Capital(分享投资),CBC Group(康桥资本), Yuanming Capital(元明资本), Sherpa Healthcare Partners(夏尔巴投资), Jiuyo Capital(久友资本), Shiyu Capital(拾玉资本), Sangel Capital(仙瞳资本), Dalton Ventures(道彤投资), Cowin Venture(凯风创投), Med-Fine Capital(幂方资本), Lang Sheng Investment(朗盛投资), Hyfinity Investments(汇鼎投资), Yunfeng Capital(云锋基金), Morningside Ventures(晨兴资本), CICC Capital(中金资本), Goldstone Investment(金石投资), SDIC Fund(国投创新), CR-CP Life Science Fund(华润生命科学基金), Sinopharm-CICC(国药中金资本), TF Capital(泰福资本), YUNION Healthcare Ventures(楹联健康基金), BOHE Angel Fund(薄荷天使基金), Bluebay Capital(蓝湾资本), Sunforest Capital(煜森资本),NNFE Investment(新毅投资), Z-Park Fund(中关村并购母基金), CLSA Capital Partners(里昂证券亚太恒富资本), and Sino Ocean Capital(远洋资本)

EVENT PARTNERS

Big Idea CONNECTpreneur Forum

SAPA sister chapters

ChinaBio

BioCentury

Deloitte

Date

Oct 17 2020

Time

Eastern Time
8:30 am - 1:30 pm

Cost

Free

More Info

Click Here

Labels

Regional Event

Location

Online Event
Category

Organizer

CONNECTpreneur
No Comments

Sorry, the comment form is closed at this time.